Telaprevir, Boceprevir Improve HCV Cure Rates. The new therapies for chronic hepatitis C are closer than ever. While we have been participating in conducting may of these trials, it has never been more exciting for both patients and physicians who care for hepatitis C patients. Here is an anaylsis from the recent AASLD meeting in Boston this month. Read more here.
Love this new feature! love this page.
Posted by: zhang | November 24, 2010 at 09:01 PM